Roger D Tung - Net Worth and Insider Trading

Roger D Tung Net Worth

The estimated net worth of Roger D Tung is at least $9 Million dollars as of 2024-06-06. Roger D Tung is the CEO of Concert Pharmaceuticals Inc and owns about 1,118,554 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $9 Million. Details can be seen in Roger D Tung's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Roger D Tung has not made any transactions after 2023-01-06 and currently still holds the listed stock(s).

Transaction Summary of Roger D Tung

To

Roger D Tung Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Roger D Tung owns 2 companies in total, including Concert Pharmaceuticals Inc (CNCE) , and Salarius Pharmaceuticals Inc (SLRX) .

Click here to see the complete history of Roger D Tung’s form 4 insider trades.

Insider Ownership Summary of Roger D Tung

Ticker Comapny Transaction Date Type of Owner
CNCE Concert Pharmaceuticals Inc 2023-01-06 director & Chief Executive Officer
SLRX Salarius Pharmaceuticals Inc 2017-10-30 director

Roger D Tung Latest Holdings Summary

Roger D Tung currently owns a total of 1 stock. Roger D Tung owns 1,118,554 shares of Concert Pharmaceuticals Inc (CNCE) as of January 6, 2023, with a value of $9 Million.

Latest Holdings of Roger D Tung

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNCE Concert Pharmaceuticals Inc 2023-01-06 1,118,554 8.37 9,362,297

Holding Weightings of Roger D Tung


Roger D Tung Form 4 Trading Tracker

According to the SEC Form 4 filings, Roger D Tung has made a total of 3 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 9,240 shares on January 6, 2023, which brought Roger D Tung around $66,898.

Insider Trading History of Roger D Tung

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Roger D Tung Trading Performance

GuruFocus tracks the stock performance after each of Roger D Tung's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roger D Tung is 4.36%. GuruFocus also compares Roger D Tung's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roger D Tung within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Roger D Tung's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Roger D Tung

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.1 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 16.57 LIMIT LIMIT LIMIT LIMIT LIMIT

Roger D Tung Ownership Network

Ownership Network List of Roger D Tung

No Data

Ownership Network Relation of Roger D Tung

Insider Network Chart

Roger D Tung Owned Company Details

What does Concert Pharmaceuticals Inc do?

Who are the key executives at Concert Pharmaceuticals Inc?

Roger D Tung is the director & Chief Executive Officer of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include Chief Development Officer James V Cassella , CFO & PFO Marc A. Becker , and Chief Operating Officer Nancy Stuart .

Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary

Over the past 18 months, Roger D Tung made 1 insider transaction in Concert Pharmaceuticals Inc (CNCE) with a net sale of 9,240. Other recent insider transactions involving Concert Pharmaceuticals Inc (CNCE) include a net sale of 16,093 shares made by Nancy Stuart , a net sale of 12,999 shares made by James V Cassella , and a net sale of 11,386 shares made by Marc A. Becker .

In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 61,104 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 61,104 shares.

Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Concert Pharmaceuticals Inc Insider Transactions

No Available Data

Roger D Tung Mailing Address

Above is the net worth, insider trading, and ownership report for Roger D Tung. You might contact Roger D Tung via mailing address: 99 Hayden Avenue, Suite 500, Lexington Ma 02421.

Discussions on Roger D Tung

No discussions yet.